Literature DB >> 9797140

The 5'-flanking region of human CD24 gene has cell-type-specific promoter activity in small-cell lung cancer.

M K Pass1, G Quintini, J A Zarn, S M Zimmermann, J A Sigrist, R A Stahel.   

Abstract

The human surface antigen CD24 is over-expressed in small-cell lung cancer. Here we describe the isolation, sequencing and functional characterization of the 5'-flanking region of the human CD24 gene. A sequence (accession number: Y14692) of 3.4 kb regulates the activity of a luciferase reporter gene in CD24-expressing small-cell-lung-cancer cell lines up to 1.6-fold more than the control SV40 promoter and enhancer. In contrast, little or no luciferase activity was detected in 4 non-small-cell-lung-cancer cell lines. A deletion fragment of 269 bp had maximal activity in small-cell-lung-cancer cell lines (15- to 20-fold higher than control), while activity remained 2- to 10-fold below control in non-small-cell-lung-cancer cell lines. We conclude that the CD24 promoter has a strong and cell-type-specific activity, and propose its exploitation to drive the expression of therapeutic genes in small-cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797140     DOI: 10.1002/(sici)1097-0215(19981109)78:4<496::aid-ijc17>3.0.co;2-4

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  External Qi of Yan Xin Qigong induces cell death and gene expression alterations promoting apoptosis and inhibiting proliferation, migration and glucose metabolism in small-cell lung cancer cells.

Authors:  Xin Yan; Feng Li; Igor Dozmorov; Mark Barton Frank; Ming Dao; Michael Centola; Wei Cao; Dan Hu
Journal:  Mol Cell Biochem       Date:  2011-12-10       Impact factor: 3.396

2.  Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo.

Authors:  Zhaoxiong Ma; Hua He; Fumou Sun; Yao Xu; Xuequn Huang; Yuexing Ma; Hong Zhao; Yang Wang; Min Wang; Juan Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-23       Impact factor: 4.553

Review 3.  CD24: from A to Z.

Authors:  Xianfeng Fang; Pan Zheng; Jie Tang; Yang Liu
Journal:  Cell Mol Immunol       Date:  2010-02-15       Impact factor: 11.530

4.  CD24 expression as a marker for predicting clinical outcome in human gliomas.

Authors:  Jianping Deng; Guodong Gao; Liang Wang; Tao Wang; Jia Yu; Zhenwei Zhao
Journal:  J Biomed Biotechnol       Date:  2012-02-28

5.  Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer.

Authors:  J M Coulson; J Stanley; P J Woll
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

6.  Repression of CD24 surface protein expression by oncogenic Ras is relieved by inhibition of Raf but not MEK or PI3K.

Authors:  Nikitha K Pallegar; D Craig Ayre; Sherri L Christian
Journal:  Front Cell Dev Biol       Date:  2015-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.